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Abstract In April 2011, an international advanced course
and workshop entitled “Frontiers in Human Pluripotent
Stem Cells” and an International Congress on Fertility and
Genetics (http://www.fertigen.com.jo/ConferenceDetails.
aspx) was held in Amman Jordan hosted by the Jordanian
Society of Fertility and Genetics under the auspices of the
International Cell Research Organization (ICRO), a
UNESCO associated NGO. The Congress President Dr.
Zaid Kilani, with Dr. Abdel Latif Abu Khadra, President of
the Jordanian society for Fertility and Genetics, Dr. Rana
Dajani of the Hashemite University of Jordan, and their
Organizing Committee proved to be an excellent organizers
and dedicated physician-scientists and, focusing on fertility,
genetics and stem cells in a wide range of advanced
therapeutic applications. Brilliant course participants in-
cluded trainees, scientists and clinicians from the Greater
Middle East. The lectures and practical sessions, presented
by internationally acknowledged scientists, included over-
views of recent achievements in pluripotent stem cell
research, emphasizing the role of both the embryonic (ES)
and induced pluripotent stem (iPS) cells. A major emphasis
was placed on the clinical achievements in germ cell and
umbilical cord stem cell transplantation issues, and on the
potential of fast and successful prenatal and pre-implanta-
tion molecular genetics diagnostics. The organization of the
stem cell course in the Holy Land especially emphasized
that issues of “eternal life” and “rejuvenation” are already at
hand—at least in the pluripotent stem cell research field. In
the lively atmosphere of the course about 60 participants
had heated discussions on the possibility and ethics of
advanced prenatal diagnostics, and on regulatory issues
reflecting the need of separation of clinically effective
versus unapproved, unwarranted stem cell treatments. An
open discussion of many ethical issues, reflecting profound
differences in religion and medical tradition in the different
countries, made this course exceptionally interesting for
both teachers and trainees.
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In the middle of a wide-spread unrest in the Arab world,
this April 2011, the capital of Jordan, Amman, hosted an
international advanced course and workshop on “Frontiers
in Human Pluripotent Stem Cells” and an International
Congress on Fertility and Genetics (http://www.fertigen.
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DOI 10.1007/s12015-011-9277-zcom.jo/ConferenceDetails.aspx). The aim of the advanced
training course, organized by the International Cell Re-
search Organization (ICRO), and the Jordanian Society of
Fertility and Genetics, was to attract students and clinicians
from the neighboring countries and demonstrate the
fantastic recent achievements in the area of stem cell
research. The lectures and practical sessions, presented by
internationally acknowledged scientists, included overviews
of recent achievements in pluripotent stem cell research,
emphasizing the role of both the embryonic (ES) and
induced pluripotent stem (iPS) cells. A major emphasis was
placed on the clinical achievements in germ cell and
umbilical cord stem cell transplantation issues, and on the
potential of fast and successful prenatal and pre-
implantation molecular genetic diagnostics.
The recently “rejuvenated” ICRO, with its half-
century tradition of educating and mentoring promising
young scientists with outstanding advanced training
courses in the developing world, assured a high quality
of this event. Participation of local and international
speakers and live laboratory demonstrations made the
course a temporary center of advanced clinical technol-
ogies. Course and Congress participants came from
throughout the Greater Middle East, including Bahrain,
Egypt, Iran, Iran, Libya, the Palestinian Territories, Syria
and, of course, our host country, the Hashemite Kingdom
of Jordan. The organization of the stem cell course in the
Holy Land especially emphasized that issues of “eternal
life” and “rejuvenation” are already at hand—at least in
the pluripotent stem cell research field.
In the lively atmosphere of the course about 60
participants had heated discussions on the possibility and
ethics of advanced prenatal diagnostics, and on regulatory
issues reflecting the need of separation of clinically
effective versus unapproved, unwarranted stem cell treat-
ments. An open discussion of many ethical issues, reflect-
ing profound differences in religion and medical tradition in
the different countries, made this course exceptionally
interesting for both teachers and students. Dr. Zaid Kilani,
the Congress President, together with Dr. Abdel Latif Abu
Khadra, President of the Jordanian society for Fertility and
Genetics, Dr. Rana Dajani of the Hashemite University of
Jordan, and their Organizing Committee proved to be an
excellent organizers and dedicated physician-scientists and,
focusing on fertility, genetics and stem cells in a wide range
of advanced therapeutic applications.
The International Congress, closely attached to the
advanced course, brought both scientific events to a
magnificent social gathering. The Congress was opened
by Jordanian Princess H.R.H. Basma Bint Talal, the late
King Hussein’s sister and King Abdullah’s Aunt (Fig. 1).
To a great joy of the guest scholars, she gave an excellent
free talk in English on the need of modern biological
science to flourish even further in the Muslim world, so
well known about its eminent classical scholars. She
especially emphasized the need for modern medicine in
the area of fertility, thus liberating women and promoting
their health at this part of the world as well. As we learned
later, in fact, at the time of need she went to the Mayo
clinic to donate her bone marrow for King Hussein’ss t e m
cell therapy.
Course organizers noted that it is rare in the Middle East
to have in depth training courses and this gave the
participants the flavor of how investigations are conducted
in the United States and Europe as well as opening new
horizons and opportunities to speak with internationally
renowned scientists. In addition to the many physician-
scientists in the workshop and congress, there were about a
dozen fundamental doctoral trainees in the course and
perhaps twice that number in the Congress.
Culture, art—and as we believe—science could easily
bring together people even with widely different views and
ambitions, and thus may make this troubled part of the
world a new melting pot of scientific achievements and
advanced medical technologies.
Fig. 1 Opening Session of the JORDIAN SOCIETY FOR FERTILITY
AND GENETICS Congress and Commencement for the Stem Cell
Workshop. High Royal Highness Princess Basma Bint Talal of Jordan
(Center). Dr. Zaid Kilani is directly to her right and the authors (B.S.; 3rd
right and G.S.; her left) are also in this figure together with many of the
speakers
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Appendix
International Cell Research Organization (ICRO) proudly announces a new laboratory course entitled:
FRONTIERS IN HUMAN PLURIPOTENT STEM CELLS
Amman JORDAN April 20–23, 2011
Under the Auspices of the:
JORDANIAN SOCIETY FOR FERTILITY AND GENETICS AND THE FARAH HOSPITAL
Organized by: Abdel Latif Abu Khadra, MD (Jordan); Rana Dajani, PhD (Jordan); Zaid Kilani, MD (Jordan); Maya
Mitalipova, PhD (USA, Kazakhstan); Gerald Schatten, PhD (USA)
Advisory Committee: H. Baharvand PhD (Iran), P. Braude MD (UK), H. Gourabi PhD (Iran), F. Kilani, MD (Jordan), S.
Kilani MD (Jordan), J. Pruszak MD (Germany, USA), M. Sarhan, MD (Jordan), P. Schlegel MD (USA),
S. Schlatt PhD (Germany), J. Shay PhD (USA)
Patient-Specific Disease-Expressing Pluripotent Stem Cells for Medical Discoveries
8:30 AM Welcome and Introduction
8:45 AM Pluripotent Stem Cells—G. Schatten
9A M Lab Demo: Culture, passaging and characterizations –
C. Simerly, C. Easley
9:45 Marcus Hughes, MD, PhD (US) Stem Cells and PGD Frontiers
10:45 Patient-Specific PSCs Established by Induced Pluripotency
Lab Demo: PSC derivations by iPS; Chas Easley, C. Simerly
1:00 PM Clinical Observations on Therapeutic Opportunities in Male infertility- Peter Schlegel, MD
1:20 Lab Demo: Male Germ Cell Transplantation - Stefan Schlatt, Dr. rer. nat.
3 PM Neuroprogenitors from PSCs—Jan Pruszak, MD
Lab Demo: Neuroprogenitor differentiation
3:40 PM Challenges and Opportunities iPSCs for Clinical Introduction;
B. Sarkardi (Hungary)
4 PM Umbilical Cord Stem Cell Transplantation—Mahmoud Sarhan, MD
4:20 PM Cancer Stem Cells—Jerry Shay, PhD
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I REPRODUCTIVE SURGERY
TITLE SPEAKER COUNTRY
9:00–9:30 Endometrioma and IVF: to touch or not to touch Juan Garcia-Velasco Spain
9:30–10:00 The long term effects of electrocautery of the ovaries in
PCOS
Fulco Van Der Veen Netherland
10:00–10:30 Embryo transfer can we improve it? Rene Frydman France
10:30–11:00 Coffee break
II KEYNOTE LECTURES
TITLE SPEAKER COUNTRY
11:00–11:45 Progesterone induced blood flow in improving pregnancy
outcome
Salim Daya Canada
11:45–12:30 Modern ART in today's society Jurgis Gedis Grudzinskas UK
12:30–2:00 Lunch break session: Hot controversial Topics in ART
III MALE INFERTILITY
TITLE SPEAKER COUNTRY
2:00–2:30 What's new with diagnosing sperm defects? Christopher Barratt UK
2:30–3:00 Non-obstructive azoospermia:Evolution of treatment Peter Schlegel USA
3:00–3:30 Repeated micro-dissection TESE: is there a limit? Abdel Latif Abu Khadra Jordan
3:30–4:00 Coffee break
IV REPRODUCTIVE GENETICS
TITLE SPEAKER COUNTRY
4:00–4:30 Clinical aspects of globozoospermia Christopher Barratt UK
4:30–5:00 Genetics of infertility : how to clone human genes solely
involved in infertility phenotype
Stephane Vivilli France
5:00–5:30 What have stem cells taught us about early human
embryology
Peter Braude UK
FRIDAY
V INFERTILITY MANAGEMENT
TITLE SPEAKER COUNTRY
9:00–9:30 The pros and cons of IUI Willem Ombelet Belgium
9:30–10:00 GnRH antagonists are safer than agonists Hesham Al Inany Egypt
10:00–10:30 OHSS risk reduction/prevention in ART Peter Humaidan Denmark
10:30–11:00 Coffee break
VI KEYNOTE LECTURES
TITLE SPEAKER COUNTRY
11:00–11:45 Managing male infertility in the 21st century: Optimizing
diagnostic and treatments by mechanistic understandings
and avoiding intractable male infertility
Gerald Schatten USA
11:45–12:30 Preimplantation Genetics in 2011: The Promise and
The Controversies
Mark Hughes USA
12:30–2:30 Lunch break
VII IVF LAB
TITLE SPEAKER COUNTRY
2:30–3:00 New developments on sperm selection for ICSI Willem Ombelet Belgium
3:00–3:30 Objective markers of oocyte and embryo viability Marcos Meseguer Spain
3:30–4:00 Impact of lifestyle factors and antioxidative treatment
on sperm analysis results (WHO AND MSOME criteria)
Johannes Wogatzky Austria
4:00–4:30 Coffee break
VIII CLINICAL ART
TITLE SPEAKER COUNTRY
4:30–5:00 Evidenced based management of poor ovarian response Stratis Kolibianakis Greece
5:00–5:30 “Single Embryo Transfer: The way ahead?” Peter Brinsden UK
5:30–6:00 closing remarks Peter Brinsden UK
90 Stem Cell Rev and Rep (2012) 8:87–90